Literature DB >> 11485836

Differential effects of two NMDA receptor antagonists on cognitive--behavioral performance in young nonhuman primates II.

E J Popke1, R R Allen, E C Pearson, T G Hammond, M G Paule.   

Abstract

The present experiment examined the effects of chronic exposure to remacemide (an NMDA antagonist that also blocks fast sodium channels) or MK-801 (which blocks NMDA receptors more selectively) on the acquisition of color and position discrimination and short-term memory behavior in juvenile rhesus monkeys. Throughout the 2-year dosing period, a conditioned position responding (CPR) task was used to assess color and position discrimination and a delayed matching-to-sample (DMTS) task was used to assess memory. Chronic exposure to high doses of either drug delayed the acquisition of accurate color and position discrimination without altering response rates. In the case of MK-801, these effects abated within 6 months of the start of treatment. In the case of remacemide, the effects persisted for 17 months of dosing. Neither compound significantly altered performance of the short-term memory task at any time point or at any dose tested. The fact that the effects of remacemide on behavioral performance were more persistent than those seen for MK-801 suggests that tolerance may develop to the behavioral effects of MK-801, which does not develop to the effects of remacemide. Alternatively, these results may suggest that the concurrent antagonism of NMDA receptors and fast sodium channels may have more profound consequences for behavior than does the antagonism of NMDA receptors alone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485836     DOI: 10.1016/s0892-0362(01)00138-6

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  7 in total

1.  Behavioral toxicology of cognition: extrapolation from experimental animal models to humans: behavioral toxicology symposium overview.

Authors:  Merle G Paule; Leonard Green; Joel Myerson; Maria Alvarado; Jocelyne Bachevalier; Jay S Schneider; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2012-01-28       Impact factor: 3.763

Review 2.  Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Authors:  Ronald N Hines; Dana Sargent; Herman Autrup; Linda S Birnbaum; Robert L Brent; Nancy G Doerrer; Elaine A Cohen Hubal; Daland R Juberg; Christian Laurent; Robert Luebke; Klaus Olejniczak; Christopher J Portier; William Slikker
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

3.  Peripheral fibroblast metabolic pathway alterations in juvenile rhesus monkeys undergoing long-term fluoxetine administration.

Authors:  Shu-Yi Su; Casey E Hogrefe-Phi; John M Asara; Christoph W Turck; Mari S Golub
Journal:  Eur Neuropsychopharmacol       Date:  2016-04-12       Impact factor: 4.600

4.  Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys.

Authors:  M G Paule; M Li; R R Allen; F Liu; X Zou; C Hotchkiss; J P Hanig; T A Patterson; W Slikker; C Wang
Journal:  Neurotoxicol Teratol       Date:  2011-01-15       Impact factor: 3.763

5.  The effects of chronic methylphenidate administration on operant test battery performance in juvenile rhesus monkeys.

Authors:  J S Rodriguez; S M Morris; C E Hotchkiss; D R Doerge; R R Allen; D R Mattison; M G Paule
Journal:  Neurotoxicol Teratol       Date:  2009-09-06       Impact factor: 3.763

Review 6.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

7.  Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs.

Authors:  Christopher Andreas Turski; Chrysanthy Ikonomidou
Journal:  Front Neurol       Date:  2012-08-01       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.